Publications

Breast cancer research and treatment

Erratum to: The effect of trastuzumab-based chemotherapy in small node-negative HER2-positive breast cancer.

01-09-2016

British journal of clinical pharmacology

Pronounced between-subject and circadian variability in thymidylate synthase and dihydropyrimidine dehydrogenase enzyme activity in human volunteers.

01-09-2016

Chromosoma

The upstreams and downstreams of H3K79 methylation by DOT1L.

01-09-2016

European journal of cancer (Oxford, England : 1990)

Proportions of blood-borne Vδ1+ and Vδ2+ T-cells are associated with overall survival of melanoma patients treated with ipilimumab.

01-09-2016

Journal of biomedical optics

In vivo characterization of colorectal metastases in human liver using diffuse reflectance spectroscopy: toward guidance in oncological procedures.

01-09-2016

Bioinformatics (Oxford, England)

TANDEM: a two-stage approach to maximize interpretability of drug response models based on multiple molecular data types.

01-09-2016

Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation

Erratum to: Using a discrete choice experiment to value the QLU-C10D: feasibility and sensitivity to presentation format.

01-09-2016

Journal of cachexia, sarcopenia and muscle

Loss of skeletal muscle during neoadjuvant chemotherapy is related to decreased survival in ovarian cancer patients.

01-09-2016

Cell cycle (Georgetown, Tex.)

Monitoring amino acid deficiencies in cancer.

01-09-2016

Annals of oncology : official journal of the European Society for Medical Oncology

Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

01-09-2016

International journal of radiation oncology, biology, physics

Validation of High-Risk Computed Tomography Features for Detection of Local Recurrence After Stereotactic Body Radiation Therapy for Early-Stage Non-Small Cell Lung Cancer.

01-09-2016

Human molecular genetics

An intergenic risk locus containing an enhancer deletion in 2q35 modulates breast cancer risk by deregulating IGFBP5 expression.

01-09-2016

The New England journal of medicine

Mutations Associated with Acquired Resistance to PD-1 Blockade in Melanoma.

01-09-2016

Anti-cancer drugs

Cytosine arabinoside and daunorubicin induction therapy in a patient with acute myeloid leukemia on chronic hemodialysis.

01-09-2016

Cancer discovery

Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types.

01-09-2016

European journal of nuclear medicine and molecular imaging

Fluorescence guided surgery and tracer-dose, fact or fiction?

01-09-2016

Virchows Archiv : an international journal of pathology

An international study comparing conventional versus mRNA level testing (TargetPrint) for ER, PR, and HER2 status of breast cancer.

01-09-2016

Nuclear medicine communications

Accuracy of PET/MRI coregistration of cervical lesions.

01-09-2016

Cancers

Imaging in Colorectal Cancer: Progress and Challenges for the Clinicians.

31-08-2016

Nature communications

Hypersensitivity to DNA damage in antephase as a safeguard for genome stability.

26-08-2016

PloS one

Fine-Mapping of the 1p11.2 Breast Cancer Susceptibility Locus.

25-08-2016

Preventing chronic disease

The Precarious Health of Young Mexican American Men in South Texas, Cameron County Hispanic Cohort, 2004-2015.

25-08-2016

The New England journal of medicine

70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer.

25-08-2016

Cell reports

PTEN Loss in E-Cadherin-Deficient Mouse Mammary Epithelial Cells Rescues Apoptosis and Results in Development of Classical Invasive Lobular Carcinoma.

23-08-2016

Oncology

Enzalutamide as a Fourth- or Fifth-Line Treatment Option for Metastatic Castration-Resistant Prostate Cancer.

22-08-2016

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Reply to D. Vordermark and T. Pelz and R. Mazzola et al.

20-08-2016

Oncogene

A p53-bound enhancer region controls a long intergenic noncoding RNA required for p53 stress response.

18-08-2016

Oncogenesis

RNF168 cooperates with RNF8 to mediate FOXM1 ubiquitination and degradation in breast cancer epirubicin treatment.

15-08-2016

International journal of cancer

BRCA1-like profile predicts benefit of tandem high dose epirubicin-cyclophospamide-thiotepa in high risk breast cancer patients randomized in the WSG-AM01 trial.

15-08-2016

Oncogene

CFTR is a tumor suppressor gene in murine and human intestinal cancer.

11-08-2016

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Age- and Tumor Subtype-Specific Breast Cancer Risk Estimates for CHEK2*1100delC Carriers.

10-08-2016

Breast cancer research : BCR

Survival is associated with complete response on MRI after neoadjuvant chemotherapy in ER-positive HER2-negative breast cancer.

05-08-2016

Oncogene

Molecular mechanisms of target recognition by lipid GPCRs: relevance for cancer.

04-08-2016

BMC cancer

Integrated molecular pathway analysis informs a synergistic combination therapy targeting PTEN/PI3K and EGFR pathways for basal-like breast cancer.

02-08-2016

Current opinion in immunology

Neoantigens encoded in the cancer genome.

01-08-2016

World journal of urology

Resection of metastasis and local recurrences of renal cell carcinoma after presurgical targeted therapy: probability of complete local control and outcome.

01-08-2016

PLoS medicine

Genetically Predicted Body Mass Index and Breast Cancer Risk: Mendelian Randomization Analyses of Data from 145,000 Women of European Descent.

01-08-2016

Nuclear medicine communications

A pilot study of SPECT/CT-based mixed-reality navigation towards the sentinel node in patients with melanoma or Merkel cell carcinoma of a lower extremity.

01-08-2016

Breast cancer research and treatment

Predictors of enduring clinical distress in women with breast cancer.

01-08-2016

Psycho-oncology

Why do patients choose (not) to participate in an exercise trial during adjuvant chemotherapy for breast cancer?

01-08-2016

Journal of biomedical optics

Navigation of a robot-integrated fluorescence laparoscope in preoperative SPECT/CT and intraoperative freehand SPECT imaging data: a phantom study.

01-08-2016

Journal of pharmaceutical analysis

Validation of a liquid chromatographic method for the pharmaceutical quality control of products containing elacridar.

01-08-2016

Clinical cancer research : an official journal of the American Association for Cancer Research

FGFR1 Is a Potential Prognostic Biomarker and Therapeutic Target in Head and Neck Squamous Cell Carcinoma.

01-08-2016

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences

Quantification of vosaroxin and its metabolites N-desmethylvosaroxin and O-desmethylvosaroxin in human plasma and urine using high-performance liquid chromatography-tandem mass spectrometry.

01-08-2016

The Lancet. Oncology

10 year survival after breast-conserving surgery plus radiotherapy compared with mastectomy in early breast cancer in the Netherlands: a population-based study.

01-08-2016

Annals of oncology : official journal of the European Society for Medical Oncology

The time to progression ratio: a new individualized volumetric parameter for the early detection of clinical benefit of targeted therapies.

01-08-2016

International journal of computer assisted radiology and surgery

Comparing position and orientation accuracy of different electromagnetic sensors for tracking during interventions.

01-08-2016

Current opinion in immunology

Editorial overview: Cancer immunology: genomics & biomarkers: Cancer immunity through the prism of genomics and proteomics.

01-08-2016

European journal of cancer (Oxford, England : 1990)

Second St. Gallen European Organisation for Research and Treatment of Cancer Gastrointestinal Cancer Conference: consensus recommendations on controversial issues in the primary treatment of rectal cancer.

01-08-2016

World journal of urology

Comparison of pre-treatment MSKCC and IMDC prognostic risk models in patients with synchronous metastatic renal cell carcinoma treated in the era of targeted therapy.

01-08-2016